Maze Therapeutics targets up to $728 mln valuation in US IPO
Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...
ENDPOINTS NEWS2h
Maze looks to lead IPO queue with $113M Nas­daq de­but
Maze Therapeutics is eyeing a $113 million initial public offering a little under two months after revealing a $115 million ...
Drug developer Maze Therapeutics eyes up to $728 million valuation in US IPO
By Arasu Kannagi Basil (Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial public offering, set to be the first U.S.
Soap's maze-solving skills could unlock secrets of the human body
An international team of scientists have discovered that soap could be important to helping our understanding of complex ...
Coder creates an 'infinite maze' to snare AI bots in an act of 'sheer unadulterated rage at how things are going' on the content-scraped web
An anonymous coder, writing to 404media under the fake name Aaron B, has also been feeling the malaise, and he's doing ...
Maze Therapeutics Files for IPO
Maze Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The San Francisco-based human genetics biotech company didn't say Tuesday how many shares it ...
autoevolution5d
Watch YangWang U7 Flagship Sedan Using Its Body Control System To Complete a Maze Game
BYD shared a video showing the YangWang U7 leveraging the Disus-Z suspension system to complete a maze game via phone control ...